NCT03779009View on ClinicalTrials.gov

Minimally INvasive Colon Cancer Surgery Through IMmunomics and Optical Mapping of the Sentinel Lymph Node.

NARecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Colon CancerSentinel Lymph Node
Interventions
OTHER

ICG-nanocoll (indocyanine green coupled to the human albumin colloidal particle nanocoll)

Under laparoscopic control, 2.0 ml of ICG-nanocoll will be injected into the subserosa at four quadrants around the tumor. Directly after injection, near infrared (NIR) fluorescence images (Olympus, Tokyo, Japan) will be acquired. SLNs will be identified and marked.

Trial Locations (1)

9000

RECRUITING

Ghent University Hospital, Ghent

All Listed Sponsors
collaborator

Kom Op Tegen Kanker

OTHER

lead

University Hospital, Ghent

OTHER